256 results on '"Picarsic, Jennifer"'
Search Results
2. Identification of Macrophages and Dendritic Cells
3. Histiocytic Pathogenesis and Derivation
4. Non-Neoplastic Accumulation of Histiocytes
5. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
6. Primary Histiocytic Disorders of the Lung
7. Lineage switching of the cellular distribution of BRAFV600E in multisystem Langerhans cell histiocytosis
8. International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults
9. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
10. CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions.
11. BRAFV600E-induced senescence drives Langerhans cell histiocytosis pathophysiology
12. Bone marrow–derived myeloid progenitors as driver mutation carriers in high- and low-risk Langerhans cell histiocytosis
13. Interleukin-18 and cytotoxic impairment are independent and synergistic causes of murine virus-induced hyperinflammation
14. Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis.
15. Prior viral infection primes cross-reactive CD8+ T cells that respond to mouse heart allografts
16. Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disorders
17. Circulating senescent myeloid cells drive blood brain barrier breakdown and neurodegeneration
18. Histiocytic disorders
19. Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms
20. Rosai–Dorfman Disease
21. Central Nervous System Langerhans Cell Histiocytosis
22. Pathology of Histiocytic Disorders and Neoplasms and Related Disorders
23. Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis
24. Childhood-onset Erdheim-Chester Disease in the molecular era: clinical phenotype and long-term outcome of 21 patients
25. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease
26. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome
27. Lorlatinib use in an infant with thalamic ALK‐positive histiocytosis
28. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
29. Contributors
30. Disorders of Histiocytes
31. Pathology of Histiocytic Disorders and Neoplasms and Related Disorders
32. Bone Marrow-Derived BRAFV600E-Mutated Cells Drive Neurodegeneration in a Mouse Model of Langerhans Cell Histiocytosis
33. Histiocytic Disorders of Childhood
34. Lineage-switching of the cellular distribution of BRAFV600E in multisystem Langerhans cell histiocytosis
35. Rosai–Dorfman Disease
36. Central Nervous System Langerhans Cell Histiocytosis
37. Expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults
38. A Chronic Eyelid Lesion in a child: Multi-Disciplinary Approach to Diagnosis, Treatment and Management of a Highly Atypical Histiocytic Lesion
39. Lineage switching of the cellular distribution of BRAFV600Ein multisystem Langerhans cell histiocytosis
40. ALK-Positive Histiocytosis—A Distinct Histiocytic Entity Deserving Recognition.
41. Langerhans cell histiocytosis and Erdheim-Chester disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAFV600E mutation
42. BRAF V600E-induced senescence drives Langerhans cell histiocytosis pathophysiology
43. Hypoplasia of Extrahepatic Biliary Tree and Intrahepatic Cholangiolopathy in Cystic Fibrosis Imperfectly Mimic Biliary Atresia in 4 Infants With Cystic Fibrosis and Kasai Portoenterostomy
44. A chronic eyelid lesion in a child: multi-disciplinary approach to diagnosis, treatment and management of a highly atypical histiocytic lesion
45. Three decades of progress from surgery to medical therapy for isolated neuroaxis BRAF V600E–positive Langerhans cell histiocytosis management: illustrative case
46. BRAF fusions in pediatric histiocytic neoplasms define distinct therapeutic responsiveness to RAF paradox breakers
47. Discrepancies between F‐18‐FDG PET/CT findings and conventional imaging in Langerhans cell histiocytosis
48. BRAF fusions in pediatric histiocytic neoplasms define distinct therapeutic responsiveness to RAF paradox breakers
49. RARE-40. CASE REPORT: LONG-TERM SURVIVOR OF A RARE, PEDIATRIC PRIMARY HISTIOCYTIC SARCOMA (HS) OF THE CENTRAL NERVOUS SYSTEM (CNS) FOLLOWING COMPLETE RESECTION, CHEMOTHERAPY AND ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (ALLO-HCT)
50. New molecular insights into the pathogenesis of lipoblastomas: clinicopathologic, immunohistochemical, and molecular analysis in pediatric cases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.